Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Growth 2024-2031

Report ID: 1358150 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Country/Region, 2017, 2022 & 2028
    2.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Type
        2.2.1 Serum Biomarkers
        2.2.2 Hepatic Fibrosis Biomarkers
        2.2.3 Apoptosis Biomarkers
        2.2.4 Oxidative Stress Biomarkers
        2.2.5 Others
    2.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type
        2.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)
        2.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue and Market Share by Type (2017-2022)
        2.3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Type (2017-2022)
    2.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Application
        2.4.1 Pharma & CRO Industry
        2.4.2 Hospitals
        2.4.3 Diagnostic Labs
        2.4.4 Academic Research Institutes
    2.5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application
        2.5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Market Share by Application (2017-2022)
        2.5.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue and Market Share by Application (2017-2022)
        2.5.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Application (2017-2022)
3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers by Company
    3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Breakdown Data by Company
        3.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales by Company (2020-2022)
        3.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Company (2020-2022)
    3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue by Company (2020-2022)
        3.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Company (2020-2022)
        3.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Company (2020-2022)
    3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Company
    3.4 Key Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Location Distribution
        3.4.2 Players NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Geographic Region
    4.1 World Historic NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Geographic Region (2017-2022)
        4.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue by Geographic Region
    4.2 World Historic NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Country/Region (2017-2022)
        4.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales by Country/Region (2017-2022)
        4.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue by Country/Region
    4.3 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth
    4.4 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth
    4.5 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth
    4.6 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth
5 Americas
    5.1 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country
        5.1.1 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022)
        5.1.2 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022)
    5.2 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type
    5.3 Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region
        6.1.1 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2017-2022)
        6.1.2 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Region (2017-2022)
    6.2 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type
    6.3 APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers by Country
        7.1.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022)
        7.1.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022)
    7.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type
    7.3 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers by Country
        8.1.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022)
        8.1.2 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022)
    8.2 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type
    8.3 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    10.3 Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    10.4 Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors
    11.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Customer
12 World Forecast Review for NASH (Non-alcoholic Steatohepatitis) Biomarkers by Geographic Region
    12.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size Forecast by Region
        12.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Region (2023-2028)
        12.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Type
    12.7 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Application
13 Key Players Analysis
    13.1 GENFIT SA
        13.1.1 GENFIT SA Company Information
        13.1.2 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.1.3 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 GENFIT SA Main Business Overview
        13.1.5 GENFIT SA Latest Developments
    13.2 Gilead Sciences, Inc. (GILD)
        13.2.1 Gilead Sciences, Inc. (GILD) Company Information
        13.2.2 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.2.3 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Gilead Sciences, Inc. (GILD) Main Business Overview
        13.2.5 Gilead Sciences, Inc. (GILD) Latest Developments
    13.3 AstraZeneca
        13.3.1 AstraZeneca Company Information
        13.3.2 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.3.3 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 AstraZeneca Main Business Overview
        13.3.5 AstraZeneca Latest Developments
    13.4 Novartis AG
        13.4.1 Novartis AG Company Information
        13.4.2 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.4.3 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Novartis AG Main Business Overview
        13.4.5 Novartis AG Latest Developments
    13.5 Bristol-Myers Squibb Company
        13.5.1 Bristol-Myers Squibb Company Company Information
        13.5.2 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.5.3 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Bristol-Myers Squibb Company Main Business Overview
        13.5.5 Bristol-Myers Squibb Company Latest Developments
    13.6 Allergan Plc
        13.6.1 Allergan Plc Company Information
        13.6.2 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.6.3 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Allergan Plc Main Business Overview
        13.6.5 Allergan Plc Latest Developments
    13.7 Novo Nordisk A/S
        13.7.1 Novo Nordisk A/S Company Information
        13.7.2 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.7.3 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Novo Nordisk A/S Main Business Overview
        13.7.5 Novo Nordisk A/S Latest Developments
    13.8 Boehringer Ingelheim
        13.8.1 Boehringer Ingelheim Company Information
        13.8.2 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.8.3 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Boehringer Ingelheim Main Business Overview
        13.8.5 Boehringer Ingelheim Latest Developments
    13.9 Pfizer Inc
        13.9.1 Pfizer Inc Company Information
        13.9.2 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
        13.9.3 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Pfizer Inc Main Business Overview
        13.9.5 Pfizer Inc Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. NASH (Non-alcoholic Steatohepatitis) Biomarkers Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Serum Biomarkers
    Table 4. Major Players of Hepatic Fibrosis Biomarkers
    Table 5. Major Players of Apoptosis Biomarkers
    Table 6. Major Players of Oxidative Stress Biomarkers
    Table 7. Major Players of Others
    Table 8. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 9. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)
    Table 10. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Type (2017-2022) & ($ million)
    Table 11. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Type (2017-2022)
    Table 12. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Type (2017-2022) & (USD/Unit)
    Table 13. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 14. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)
    Table 15. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Application (2017-2022)
    Table 16. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Application (2017-2022)
    Table 17. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Application (2017-2022) & (USD/Unit)
    Table 18. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Company (2020-2022) & (K Units)
    Table 19. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Company (2020-2022)
    Table 20. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Company (2020-2022) ($ Millions)
    Table 21. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Company (2020-2022)
    Table 22. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sale Price by Company (2020-2022) & (USD/Unit)
    Table 23. Key Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Producing Area Distribution and Sales Area
    Table 24. Players NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
    Table 25. NASH (Non-alcoholic Steatohepatitis) Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 26. New Products and Potential Entrants
    Table 27. Mergers & Acquisitions, Expansion
    Table 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Geographic Region (2017-2022) & (K Units)
    Table 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Geographic Region (2017-2022)
    Table 30. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 31. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Geographic Region (2017-2022)
    Table 32. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country/Region (2017-2022) & (K Units)
    Table 33. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country/Region (2017-2022)
    Table 34. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country/Region (2017-2022) & ($ millions)
    Table 35. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country/Region (2017-2022)
    Table 36. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022) & (K Units)
    Table 37. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2017-2022)
    Table 38. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022) & ($ Millions)
    Table 39. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2017-2022)
    Table 40. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 41. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)
    Table 42. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 43. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)
    Table 44. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2017-2022) & (K Units)
    Table 45. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2017-2022)
    Table 46. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Region (2017-2022) & ($ Millions)
    Table 47. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Region (2017-2022)
    Table 48. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 49. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)
    Table 50. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 51. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)
    Table 52. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022) & (K Units)
    Table 53. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2017-2022)
    Table 54. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022) & ($ Millions)
    Table 55. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2017-2022)
    Table 56. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 57. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)
    Table 58. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 59. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)
    Table 60. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Country (2017-2022) & (K Units)
    Table 61. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country (2017-2022)
    Table 62. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Country (2017-2022) & ($ Millions)
    Table 63. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country (2017-2022)
    Table 64. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 65. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type (2017-2022)
    Table 66. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 67. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)
    Table 68. Key Market Drivers & Growth Opportunities of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    Table 69. Key Market Challenges & Risks of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    Table 70. Key Industry Trends of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    Table 71. NASH (Non-alcoholic Steatohepatitis) Biomarkers Raw Material
    Table 72. Key Suppliers of Raw Materials
    Table 73. NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors List
    Table 74. NASH (Non-alcoholic Steatohepatitis) Biomarkers Customer List
    Table 75. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2023-2028) & (K Units)
    Table 76. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Forecast by Region
    Table 77. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 78. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2023-2028) & (K Units)
    Table 80. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 81. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Region (2023-2028) & (K Units)
    Table 82. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 83. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2023-2028) & (K Units)
    Table 84. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Country (2023-2028) & (K Units)
    Table 86. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 87. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Type (2023-2028) & (K Units)
    Table 88. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 90. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Forecast by Application (2023-2028) & (K Units)
    Table 92. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 94. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share Forecast by Application (2023-2028)
    Table 95. GENFIT SA Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 96. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 97. GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 98. GENFIT SA Main Business
    Table 99. GENFIT SA Latest Developments
    Table 100. Gilead Sciences, Inc. (GILD) Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 101. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 102. Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 103. Gilead Sciences, Inc. (GILD) Main Business
    Table 104. Gilead Sciences, Inc. (GILD) Latest Developments
    Table 105. AstraZeneca Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 106. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 107. AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 108. AstraZeneca Main Business
    Table 109. AstraZeneca Latest Developments
    Table 110. Novartis AG Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 111. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 112. Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 113. Novartis AG Main Business
    Table 114. Novartis AG Latest Developments
    Table 115. Bristol-Myers Squibb Company Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 116. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 117. Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 118. Bristol-Myers Squibb Company Main Business
    Table 119. Bristol-Myers Squibb Company Latest Developments
    Table 120. Allergan Plc Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 121. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 122. Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 123. Allergan Plc Main Business
    Table 124. Allergan Plc Latest Developments
    Table 125. Novo Nordisk A/S Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 126. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 127. Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 128. Novo Nordisk A/S Main Business
    Table 129. Novo Nordisk A/S Latest Developments
    Table 130. Boehringer Ingelheim Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 131. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 132. Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 133. Boehringer Ingelheim Main Business
    Table 134. Boehringer Ingelheim Latest Developments
    Table 135. Pfizer Inc Basic Information, NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base, Sales Area and Its Competitors
    Table 136. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Offered
    Table 137. Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 138. Pfizer Inc Main Business
    Table 139. Pfizer Inc Latest Developments
List of Figures
    Figure 1. Picture of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    Figure 2. NASH (Non-alcoholic Steatohepatitis) Biomarkers Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Serum Biomarkers
    Figure 10. Product Picture of Hepatic Fibrosis Biomarkers
    Figure 11. Product Picture of Apoptosis Biomarkers
    Figure 12. Product Picture of Oxidative Stress Biomarkers
    Figure 13. Product Picture of Others
    Figure 14. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Type in 2021
    Figure 15. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Type (2017-2022)
    Figure 16. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Pharma & CRO Industry
    Figure 17. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Pharma & CRO Industry (2017-2022) & (K Units)
    Figure 18. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Hospitals
    Figure 19. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Hospitals (2017-2022) & (K Units)
    Figure 20. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Diagnostic Labs
    Figure 21. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Diagnostic Labs (2017-2022) & (K Units)
    Figure 22. NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumed in Academic Research Institutes
    Figure 23. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market: Academic Research Institutes (2017-2022) & (K Units)
    Figure 24. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Application (2017-2022)
    Figure 25. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Application in 2021
    Figure 26. NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market by Company in 2021 ($ Million)
    Figure 27. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Company in 2021
    Figure 28. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Geographic Region (2017-2022)
    Figure 29. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Geographic Region in 2021
    Figure 30. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region (2017-2022)
    Figure 31. Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country/Region in 2021
    Figure 32. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)
    Figure 33. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)
    Figure 34. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)
    Figure 35. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)
    Figure 36. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)
    Figure 37. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)
    Figure 38. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales 2017-2022 (K Units)
    Figure 39. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue 2017-2022 ($ Millions)
    Figure 40. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2021
    Figure 41. Americas NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2021
    Figure 42. United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Canada NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Mexico NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Brazil NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 46. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Region in 2021
    Figure 47. APAC NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Regions in 2021
    Figure 48. China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 50. South Korea NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 52. India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Australia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2021
    Figure 55. Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2021
    Figure 56. Germany NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 57. France NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 58. UK NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Italy NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Russia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Market Share by Country in 2021
    Figure 62. Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Country in 2021
    Figure 63. Egypt NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 64. South Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Israel NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Turkey NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 67. GCC Country NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth 2017-2022 ($ Millions)
    Figure 68. Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers in 2021
    Figure 69. Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    Figure 70. Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers
    Figure 71. Channels of Distribution
    Figure 72. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global NASH Biomarkers Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global NASH Biomarkers Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global NASH Biomarkers Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports